According to UnivDatos, advancements in genomics and biotechnology, along with the government and regulatory support, are the major factors driving the growth of the biobanks market. As per their “Biobanks Market” report, the global market was valued at USD 83,624 million in 2024, growing at a CAGR of about 8.8% during the forecast period from 2025 - 2033 to reach USD million by 2033.

Biobanks are structured depositories where biological specimens in the form of tissues, blood, DNA, cells, and other biological and related health and demographic information are collected, processed, stored, and handled. These samples are maintained with standardized conditions to maintain quality and usability over time, to be used in research and clinical purposes. Also, biobanks are important in enhancing biomedical research, drug development, clinical diagnostics, and personalized medicine by providing access to high-quality, well-annotated biological specimens to the researcher. They enhance research in genomics, disease mechanisms, biomarker discovery, and therapy development, leading to significant improvements in healthcare outcomes and scientific innovation.

Focus on Sustainability and Green Biobanking

Emphasis on sustainability and green biobanking is becoming an emerging future market trend for the biobanking market, as biobanks seek to minimize environmental impact while ensuring sample integrity. To reduce energy use and operational expenses, biobank operators are increasingly adopting cold storage, environmentally friendly consumables, and streamlined sample-processing guidelines. Waste reduction and better use of resources are also being increasingly achieved through automation. Moreover, the increasing regulatory pressure, corporate sustainability objectives, and investor attention to environmental, social, and corporate responsibility are promoting more environmentally friendly practices in biobanks. Such initiatives have the effect not only of promoting a sustainable operation in the long term, but also of increasing the cost efficiency and brand value of biobank organizations.

Access sample report (including graphs, charts, and figures): https://univdatos.com/reports/biobanks-market?popup=report-enquiry

Rising R&D Investments Driving Expansion of the Global Biobanks Market

The development of the biobanks market is rapidly increasing due to the increased research and development activities that are fueling demand for high-quality and well-characterized biological samples. Increased R&D spending by pharmaceutical, biotechnology, and academic institutions is driving substantial research in genomics, oncology, rare diseases, and precision medicine. Biobanks play a vital role in drug and biomarker discovery and in clinical trial investigations by providing uniform, traceable biospecimens. Another factor is the ongoing growth in translational research and in partnerships between industry and research institutions, which further enhances the use of biobanks, expands infrastructure, and, in the long term, expands the market.

For instance, in January 2025, UK Biobank launched the world’s most comprehensive protein study, aiming to measure up to 5,400 proteins in 600,000 samples to create an unprecedented proteomics database and transform disease research and treatment. The project was set to accelerate the discovery of biomarkers, improve disease prediction, and support drug development by combining protein data with genetic and imaging information for researchers worldwide.

Sustainability and R&D Investments Fuel Global Biobanking Growth

Regulatory pressures and corporate responsibility are driving the biobanking market toward more sustainable practices, including energy-efficient cold storage, eco-friendly consumables, automation to minimize waste and costs, and green practices. At the same time, an increase in R&D in pharmaceuticals, biotechnology, and academia is driving the need to produce high-quality biological samples, which are used in drug discovery, clinical trials, and translational research, which in turn expands the market and the healthcare infrastructure across the globe.

Related Reports:-

Biotechnology Market: Current Analysis and Forecast (2021-2027)

Digital Pathology Market: Current Analysis and Forecast (2021-2027)

Blood Clot Retrieval Devices Market: Current Analysis and Forecast (2025-2033)

Southeast Asia Pacemakers Market: Current Analysis and Forecast (2025-2033)

Premenstrual Syndrome Treatment Market: Current Analysis and Forecast (2025-2033)

Contact Us:

UnivDatos

Contact Number - +1 978 733 0253

Email - contact@univdatos.com 

Website - www.univdatos.com

Linkedin- https://www.linkedin.com/company/univ-datos-market-insight/mycompany/